Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer
March 02, 2023 09:00 ET
|
Oncocyte Corporation
IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that Joshua Riggs has been appointed as its Chief Executive...
Oncocyte Completes Razor Genomics Transaction
February 22, 2023 08:00 ET
|
Oncocyte Corporation
Company retains 30% stake while eliminating operating expense and future development obligations Represents next step in plan to focus product strategy IRVINE, Calif., Feb. 22, 2023 (GLOBE...
Oncocyte Announces Initiatives to Focus Corporate Strategy
December 16, 2022 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced a reduction in force involving over 40% of Oncocyte’s workforce...
Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors
November 30, 2022 18:05 ET
|
Oncocyte Corporation
IRVINE, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
Oncocyte Announces Executive Leadership Changes
November 30, 2022 18:00 ET
|
Oncocyte Corporation
IRVINE, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
Oncocyte Reports Third Quarter 2022 Financial Results
November 10, 2022 16:30 ET
|
Oncocyte Corporation
IRVINE, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
Oncocyte to Announce Third Quarter 2022 Financial Results
October 27, 2022 16:01 ET
|
Oncocyte Corporation
IRVINE, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
DetermaIO™ Clinical Test to be used in SWOG Cancer Research Network Biomarker Study for Breast Cancer
October 06, 2022 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
Oncocyte Announces Unanimous Recommendation from the Advisory Panel for Clinical Diagnostic Laboratory Tests on DetermaRx to CMS
September 07, 2022 08:00 ET
|
Oncocyte Corporation
IRVINE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...
Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference
August 31, 2022 16:01 ET
|
Oncocyte Corporation
IRVINE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights...